127 related articles for article (PubMed ID: 15368569)
1. An Approach towards the quantitative structure-activity relationships of caffeic acid and its derivatives.
Verma RP; Hansch C
Chembiochem; 2004 Sep; 5(9):1188-95. PubMed ID: 15368569
[TBL] [Abstract][Full Text] [Related]
2. Chemistry and biological activities of caffeic acid derivatives from Salvia miltiorrhiza.
Jiang RW; Lau KM; Hon PM; Mak TC; Woo KS; Fung KP
Curr Med Chem; 2005; 12(2):237-46. PubMed ID: 15638738
[TBL] [Abstract][Full Text] [Related]
3. [Lipophilic derivatives of caffeic acid as lipoxygenase inhibitors with antioxidant properties].
Mirzoeva OK; Sud'ina GF; Pushkareva MA; Korshunova GA; Sumbatian NV; Varfolomeev SD
Bioorg Khim; 1995 Feb; 21(2):143-51. PubMed ID: 7538294
[TBL] [Abstract][Full Text] [Related]
4. Inhibition of neutrophil elastase and thrombin activity by caffeic acid esters.
Melzig MF; Tran GD; Henke K; Selassie CD; Verma RP
Pharmazie; 2005 Nov; 60(11):869-73. PubMed ID: 16320952
[TBL] [Abstract][Full Text] [Related]
5. Lipoxygenase inhibitors: a comparative QSAR study review and evaluation of new QSARs.
Pontiki E; Hadjipavlou-Litina D
Med Res Rev; 2008 Jan; 28(1):39-117. PubMed ID: 17191217
[TBL] [Abstract][Full Text] [Related]
6. Synthesis, anti-fungal and 1,3-β-D-glucan synthase inhibitory activities of caffeic and quinic acid derivatives.
Ma CM; Abe T; Komiyama T; Wang W; Hattori M; Daneshtalab M
Bioorg Med Chem; 2010 Oct; 18(19):7009-14. PubMed ID: 20813534
[TBL] [Abstract][Full Text] [Related]
7. Caffeic acid derivatives: in vitro and in vivo anti-inflammatory properties.
da Cunha FM; Duma D; Assreuy J; Buzzi FC; Niero R; Campos MM; Calixto JB
Free Radic Res; 2004 Nov; 38(11):1241-53. PubMed ID: 15621702
[TBL] [Abstract][Full Text] [Related]
8. Synthesis, anti-HIV and anti-oxidant activities of caffeoyl 5,6-anhydroquinic acid derivatives.
Ma CM; Kawahata T; Hattori M; Otake T; Wang L; Daneshtalab M
Bioorg Med Chem; 2010 Jan; 18(2):863-9. PubMed ID: 20004585
[TBL] [Abstract][Full Text] [Related]
9. Synthesis and antitumor activity of feruloyl and caffeoyl derivatives.
Chen HZ; Chen YB; Lv YP; Zeng F; Zhang J; Zhou YL; Li HB; Chen LF; Zhou BJ; Gao JR; Xia CN
Bioorg Med Chem Lett; 2014 Sep; 24(18):4367-4371. PubMed ID: 25160837
[TBL] [Abstract][Full Text] [Related]
10. Design, synthesis and evaluation of semi-synthetic triazole-containing caffeic acid analogues as 5-lipoxygenase inhibitors.
De Lucia D; Lucio OM; Musio B; Bender A; Listing M; Dennhardt S; Koeberle A; Garscha U; Rizzo R; Manfredini S; Werz O; Ley SV
Eur J Med Chem; 2015 Aug; 101():573-83. PubMed ID: 26197161
[TBL] [Abstract][Full Text] [Related]
11. Inhibitory effect of the alkyl side chain of caffeic acid analogues on lipopolysaccharide-induced nitric oxide production in RAW264.7 macrophages.
Uwai K; Osanai Y; Imaizumi T; Kanno S; Takeshita M; Ishikawa M
Bioorg Med Chem; 2008 Aug; 16(16):7795-803. PubMed ID: 18667320
[TBL] [Abstract][Full Text] [Related]
12. Synthesis and 5-lipoxygenase inhibitory activity of new cinnamoyl and caffeoyl clusters.
Doiron J; Boudreau LH; Picot N; Villebonet B; Surette ME; Touaibia M
Bioorg Med Chem Lett; 2009 Feb; 19(4):1118-21. PubMed ID: 19152786
[TBL] [Abstract][Full Text] [Related]
13. Further discovery of caffeic acid derivatives as novel influenza neuraminidase inhibitors.
Xie Y; Huang B; Yu K; Xu W
Bioorg Med Chem; 2013 Dec; 21(24):7715-23. PubMed ID: 24262883
[TBL] [Abstract][Full Text] [Related]
14. Biological activity evaluation and structure-activity relationships analysis of ferulic acid and caffeic acid derivatives for anticancer.
Li W; Li N; Tang Y; Li B; Liu L; Zhang X; Fu H; Duan JA
Bioorg Med Chem Lett; 2012 Oct; 22(19):6085-8. PubMed ID: 22954735
[TBL] [Abstract][Full Text] [Related]
15. NMR metabolomics analysis of the effects of 5-lipoxygenase inhibitors on metabolism in glioblastomas.
Morin P; Ferguson D; LeBlanc LM; Hébert MJ; Paré AF; Jean-François J; Surette ME; Touaibia M; Cuperlovic-Culf M
J Proteome Res; 2013 May; 12(5):2165-76. PubMed ID: 23557402
[TBL] [Abstract][Full Text] [Related]
16. Structural basis for the inhibition of AKR1B10 by caffeic acid phenethyl ester (CAPE).
Zhang L; Zhang H; Zheng X; Zhao Y; Chen S; Chen Y; Zhang R; Li Q; Hu X
ChemMedChem; 2014 Apr; 9(4):706-9. PubMed ID: 24436249
[TBL] [Abstract][Full Text] [Related]
17. Caffeic acid derivatives: a new type of influenza neuraminidase inhibitors.
Xie Y; Huang B; Yu K; Shi F; Liu T; Xu W
Bioorg Med Chem Lett; 2013 Jun; 23(12):3556-60. PubMed ID: 23664211
[TBL] [Abstract][Full Text] [Related]
18. Inhibitory activities and inhibition specificities of caffeic acid derivatives and related compounds toward 5-lipoxygenase.
Sugiura M; Naito Y; Yamaura Y; Fukaya C; Yokoyama K
Chem Pharm Bull (Tokyo); 1989 Apr; 37(4):1039-43. PubMed ID: 2766406
[TBL] [Abstract][Full Text] [Related]
19. Caffeic Acid, a versatile pharmacophore: an overview.
Touaibia M; Jean-François J; Doiron J
Mini Rev Med Chem; 2011 Jul; 11(8):695-713. PubMed ID: 21679136
[TBL] [Abstract][Full Text] [Related]
20. Molecular modifications on carboxylic acid derivatives as potent histone deacetylase inhibitors: Activity and docking studies.
Bora-Tatar G; Dayangaç-Erden D; Demir AS; Dalkara S; Yelekçi K; Erdem-Yurter H
Bioorg Med Chem; 2009 Jul; 17(14):5219-28. PubMed ID: 19520580
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
